Sign up to save your podcasts
Or
Share A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.
Read the related article in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
285285 ratings
Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.
Read the related article in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
NEJM This Week
322 Listeners
JAMA Clinical Reviews
505 Listeners
Practical Neurology Podcast
53 Listeners
The Curbsiders Internal Medicine Podcast
3,375 Listeners
JAMA Neurology Author Interviews
15 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
Neurology Today in 5
25 Listeners
Annals On Call Podcast
196 Listeners
The Clinical Problem Solvers
520 Listeners
Neurology Minute
135 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
365 Listeners
Neurology Exam Prep Podcast
189 Listeners
The Curious Clinicians
378 Listeners
Ninja Nerd
322 Listeners
Continuum Audio
83 Listeners